 |
<p>Yukimasa Shiotsu, PhD, is Director of Translational Oncology for Kyowa Hakko Kirin California. He has more than 15 years experience in oncology research/development and has managed several... |
Date: April 11, 2013
Speakers: Yukimasa Shiotsu Run Time: 18 minutes |
|
↧
Translational Oncology activity of Kyowa Kirin, Discovery and development of CCR4 monoclonal antibody, mogamulizumab - Yukimasa Shiotsu, PhD, Kyowa Hakko Kirin California Inc.
↧